Cartalax 20mg

£54.99

Research Studies:

  • Facilitates analysis of tissue-specific gene expression within the musculoskeletal system and cartilage tissue
  • Supports investigation into the regulation of collagen type II and proteoglycan synthesis pathways
  • Enables research on the modulation of inflammatory cytokine expression and oxidative stress in chondrocytes
  • Useful for evaluating the epigenetic regulation of cellular repair mechanisms in connective tissue assay models
SKU: A-24970 Category: Tags: ,
Description

Cartalax 20mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details

  • Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
  • Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
  • Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
  • Produced with lot-level traceability to support research documentation and laboratory recordkeeping.

Research Documentation Context

  • Supports compound characterization in controlled laboratory settings.
  • Provides batch-specific identity and purity documentation for research review.
  • Allows lot-level traceability across laboratory documentation workflows.
  • Supports comparison of product labeling, analytical documentation, and storage information during research planning.
  • Supports analytical review of short peptide research materials within a strictly laboratory-focused context.

Specifications and Documentation

  • Certificate of Analysis: Available with batch-specific documentation where applicable.
  • Material Safety Data Sheet: Coming Soon.
  • Handling and Storage Instructions: Coming Soon.
  • Product Form: Lyophilized powder.
  • Purity Specification: ≥99% purity.
  • Intended Use: Laboratory research use only.

Cartalax 20mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.

Additional information
CAS No.

Not officially assigned (peptide bioregulator complex)

Molecular Formula

Peptide complex (exact structure proprietary)

Molecular Weight

Varies (approx. low molecular weight peptide fraction)

Purity

≥99%

Sequence

Not publicly disclosed (peptide complex derived from calf cartilage)

Synthesis Method

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Water/Sterile Diluent

Stability & Storage

Up to 24 months at -20°C. Avoid repeated freeze-thaw cycles.

Applications

Cartilage regeneration

,

joint health research

,

musculoskeletal tissue studies

Appearance

White to off-white powder

Regulatory/Compliance

Not for human consumption. For research use only.

Safety Information

MSDS available upon request

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.